GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Smith & Nephew PLC (LSE:SN.) » Definitions » Institutional Ownership

Smith & Nephew (LSE:SN.) Institutional Ownership : 56.40% (As of May. 19, 2024)


View and export this data going back to 1951. Start your Free Trial

What is Smith & Nephew Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Smith & Nephew's institutional ownership is 56.40%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Smith & Nephew's Insider Ownership is 0.30%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Smith & Nephew's Float Percentage Of Total Shares Outstanding is 0.00%.


Smith & Nephew Institutional Ownership Historical Data

The historical data trend for Smith & Nephew's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smith & Nephew Institutional Ownership Chart

Smith & Nephew Historical Data

The historical data trend for Smith & Nephew can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 52.09 52.21 52.96 52.68 52.96 53.56 53.48 53.70 56.59 56.40

Smith & Nephew Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Smith & Nephew (LSE:SN.) Business Description

Traded in Other Exchanges
Address
Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew (LSE:SN.) Headlines

No Headlines